TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SOLV

Solventum Corp.

Healthcare · Medical Instruments & Supplies

87.90$ +0.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Solventum Corp. (SOLV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 14,243 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SOLV
Line item Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 13,594 13,641 13,641 13,873 13,943 14,711 14,578 14,745 14,457 14,527 15,074 13,973 14,294 14,097 14,243
91 – – 2,231 61 2,285 2,656 2,519 3,359 3,363 3,354 3,249 3,053 3,208 4,407 3,859 3,583 3,741
-91 – – 61 -61 39 500 194 996 897 772 762 534 492 1,642 878 561 403
91 – – 61 61 39 500 194 996 897 772 762 534 492 1,642 878 561 403
– – – 1,171 1,203 1,203 1,153 1,313 1,220 1,317 1,105 1,229 1,111 1,255 1,019 1,034 1,059 1,432
– – – 873 880 880 849 857 901 899 953 965 866 962 1,049 1,066 1,089 1,040
– – – 6,434 6,503 6,503 6,402 6,535 6,468 6,447 6,592 6,377 4,991 5,274 5,260 5,704 5,626 5,626
– – – 3,252 3,080 3,080 2,977 2,902 2,810 2,724 2,651 2,544 2,365 2,302 2,223 2,592 2,497 2,408
-12,059 – – 1,852 1,912 1,912 10,623 2,277 10,860 11,711 11,553 11,498 11,265 11,429 8,987 9,245 9,128 9,443
– – – 1,311 1,382 1,382 1,471 1,728 1,854 2,571 2,904 2,703 2,566 2,620 2,938 3,136 3,346 3,663
– – – 27 – 59 – 29 – 611 300 200 100 – – – 505 506
– – – 348 372 372 377 477 587 495 560 618 604 643 669 687 699 701
– – – – – 8,317 8,325 8,303 8,303 8,306 7,809 7,810 7,813 7,815 5,137 5,035 4,575 4,573
12,059 – – 11,742 11,742 11,729 3,250 11,666 3,851 2,867 3,192 2,959 3,262 3,645 4,986 5,049 4,969 4,800
– – – – – – – 0.0 – 89 211 242 378 468 1,734 1,797 1,810 1,902
172 172 172 172 173 173 173 173 173 174 174 175 175 175 175 175 176 174

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?